Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States (2023) Huang M, Fasching P, Haiderali A, Xue W, Yang C, Pan W, Zhou ZY, et al. Journal article Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart (R) Injector: Results of the Prospective Cohort Study REBIFLECT (2022) Rieckmann P, Ziemssen T, Penner IK, Raji A, Wagner T, Richter J, Zettl UK Journal article Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria (2021) Drexler K, Drexler H, Geissler EK, Berneburg M, Haferkamp S, Apfelbacher C Journal article Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies (2021) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Dangond F, Keller B, Jack D, Vermersch P Journal article New Technologies and Applications in Sacral Neuromodulation: An Update (2020) De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel K, Engelberg S, Van Kerrebroeck PE Journal article Developing Classifications of Laryngeal Dysplasia: The Historical Basis (2020) Hellquist H, Ferlito A, Makitie AA, Thompson LDR, Bishop JA, Agaimy A, Hernandez-Prera JC, et al. Journal article, Review article Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial (2014) Voskanyan L, Garcia-Feijoo J, Belda JI, Fea A, Jünemann A, Baudouin C Journal article